Endoluten is short peptide complex marketed as a pineal bioregulator. Researchers examine it in relation to pineal signalling, circadian function and ageing hypotheses.

Researchers study possible links with body-clock signalling and age-related change. Its proposed benefits are not established by strong clinical trials.

Proposed tissue-specific gene effects are not supported by a clearly validated receptor mechanism.

Limited regional and preclinical evidence; identity may vary between branded preparations.

No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.